<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592043</url>
  </required_header>
  <id_info>
    <org_study_id>PREMISE</org_study_id>
    <nct_id>NCT03592043</nct_id>
  </id_info>
  <brief_title>A Pan-Canadian, Retrospective Evaluation of MitraClip Safety and Efficacy</brief_title>
  <acronym>PREMISE</acronym>
  <official_title>A Retrospective Multicenter Canadian Registry of Patients With Mitral Regurgitation Undergoing Percutaneous Mitral Valve Repair With MitraClip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PREMISE Registry is a retrospective, observational study that will evaluate the efficacy
      and safety of the MitraClip in real-world Canadian practice. It will include all patients who
      have undergone MitraClip implantation in Canada to date.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In addition to evaluating efficacy and safety, PREMISE will include a description of patient
      demographics, etiology of mitral regurgitation, co-morbidities, medication use and functional
      class. It will also compare re-hospitalization for heart failure 12 months prior and 12
      months after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mitral Regurgitation (MR) severity</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalization for Heart Failure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">850</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>MitraClip</arm_group_label>
    <description>All patients who have undergone percutaneous mitral valve repair with the MitraClip system in Canada</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MitraClip</intervention_name>
    <description>Transcatheter Mitral Valve Repair with MitraClip</description>
    <arm_group_label>MitraClip</arm_group_label>
    <other_name>MitraClip Clip Delivery System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who have undergone percutaneous mitral valve repair with the MitraClip Clip
        Delivery System in Canada.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has undergone percutaneous mitral valve repair with MitraClip Clip Delivery
             System in Canada

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shamir Mehta, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute; McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Fam, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PREMISE Coordinator</last_name>
    <phone>9055212100</phone>
    <phone_ext>40442</phone_ext>
    <email>PREMISE@phri.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>premise@phri.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>July 9, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>February 26, 2019</last_update_submitted>
  <last_update_submitted_qc>February 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MitraClip</keyword>
  <keyword>Degenerative Mitral Regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

